Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000128

Chairperson & CEO sold 9,500 shares at an average $517.71 ($4,918,273)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-25 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-08-25 Sale : show line 2 in the form 10b5-1 −2,029 $516.12 $1,047,205 331,914 I
2026-08-25 Sale : show line 3 in the form 10b5-1 −2,332 $516.95 $1,205,518 329,582 I
2026-08-25 Sale : show line 4 in the form 10b5-1 −2,004 $518.08 $1,038,238 327,578 I
2026-08-25 Sale : show line 5 in the form 10b5-1 −2,387 $518.80 $1,238,375 325,191 I
2026-08-25 Sale : show line 6 in the form 10b5-1 −668 $519.91 $347,297 324,523 I
2026-08-25 Sale : show line 7 in the form 10b5-1 −80 $520.50 $41,640 324,443 I
Open-market sales · 9,500 sh · avg $517.71 · $4,918,273

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-25 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option −9,500 65,910 I
Loading xslF345X06/primarydocument.xml…